Totals
- Total revenue
- $446,871
- Total expenses
- $333,331
- Contributions and grants received
- $380,452
- Grants paid
- $57,527
- Program service revenue
- $0
- Investment income
- $66,419
- Other revenue
- $0
- Total assets, end of year
- $3,137,609
- Total liabilities, end of year
- $10,958
- Net assets or fund balances, end of year
- $3,126,651
- Program services expenses (Part IX)
- $204,981
- Management and general expenses
- $92,037
- Fundraising expenses
- $36,313
- Program service expenses (Part III)
- $204,981
Program services were 61.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$96,360
-
1d · Related organizations
$249,843
-
1f · All other contributions, gifts and grants
$34,249
-
3 · Investment income
total $70,516 · excluded $70,516
-
7a · Gross sales of assets other than inventory
securities $318,619
-
7b · Less cost or other basis and sales expenses
securities $322,716
-
7c · Gain or loss
securities -$4,097
-
7d · Net gain or loss
total -$4,097 · related or exempt -$4,097
-
8a · Fundraising events: gross income
$0
-
8a · Fundraising events: contributions included on line 1c
$96,360
-
8b · Fundraising events: direct expenses
$0
-
8c · Net income from fundraising events
total $0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $57,527 · program services $57,527
-
5 · Compensation of officers, directors and key employees
total $138,208 · program services $76,015 · management and general $41,462 · fundraising $20,731
-
7 · Other salaries and wages
total $1,190 · program services $478 · management and general $358 · fundraising $354
-
10 · Payroll taxes
total $17,613 · program services $9,687 · management and general $5,284 · fundraising $2,642
-
11a · Fees: management
total $40,000 · program services $22,000 · management and general $12,000 · fundraising $6,000
-
11c · Fees: accounting
total $12,000 · program services $6,600 · management and general $3,600 · fundraising $1,800
-
11f · Fees: investment management
total $4,614 · program services $825 · management and general $3,789
-
11g · Fees: other
total $29,408 · program services $26,408 · fundraising $3,000
-
13 · Office expenses
total $1,179 · management and general $1,179
-
23 · Insurance
total $2,006 · program services $1,103 · management and general $602 · fundraising $301
-
24a · Other expenses: BOARD OF TRUSTEES
total $29,704 · program services $4,456 · management and general $23,763 · fundraising $1,485
-
24b · Other expenses: MISC. EXPENSE
total -$118 · program services -$118 · management and general $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $571,291 · end of year $661,489
-
3 · Pledges and grants receivable
end of year $2,750
-
4 · Accounts receivable
beginning of year $53,714 · end of year $0
-
10a · Land, buildings and equipment: cost or other basis
$28,835
-
10b · Land, buildings and equipment: accumulated depreciation
$28,835
-
10c · Land, buildings and equipment, net
beginning of year $0 · end of year $0
-
11 · Investments: publicly traded securities
beginning of year $2,199,369 · end of year $2,473,370
-
17 · Accounts payable and accrued expenses
beginning of year $33,666 · end of year $10,958
-
27 · Net assets without donor restrictions
beginning of year $2,777,479 · end of year $3,102,922
-
28 · Net assets with donor restrictions
beginning of year $13,229 · end of year $23,729
Mission and programs · 2023
Mission
TO IMPROVE HUMAN HEALTH BY SUPPORTING RESEARCH, SCHOLARSHIP, AND PRACTICE.
-
INVESTIGATOR TRAINING - SUPPORT CLINICAL PHARMACY RESEARCHER EDUCATION AND DEVELOPMENT.
Expenses $71,743
-
RESEARCH GRANTS - PROVIDE RESEARCH GRANTS AND AWARDS TO SUPPORT CLINICAL PHARMACY RESEARCH.
Expenses $131,188 · Grants $57,527
-
PRACTICE-BASED RESEARCH - FACILITATE COLLABORATIVE RESEARCH THAT PROMOTES THE SAFE, EFFICACIOUS, AND COST-EFFECTIVE USE AND DELIVERY OF MEDICATIONS.
Expenses $2,050
As filed on the 2023 return.
Listed in Part VII
-
ERIKA J ERNST PHARM D BCIDP FCCP
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
ROBERT B PARKER PHARMD FCCP
CHAIR
- Total calculated
- $0
- Hours/week
- 2
-
HENRY DUNNENBERGER IV PHARM D BCPS
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
MARY W L LEE PHARM D BCPS FCCP
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
EVA M VASQUEZ PHARM D FCCP BCPS
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
MICHAEL S MADDUX PHARM D FCCP
EX-OFF ACCP EXEC DIR
- Total calculated
- $0
- Hours/week
- 1
-
KATHLEEN STRINGER
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
ELIZABETH FARRINGTON PHD BSPH FCCP
VICE-CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
P DAVID ROGERS PHARM D PHD RFCCP
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
MARC H SCHEETZ PHARM D FCCP
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
KELLY E CAUDLE PHARM D PHD FCCP
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
BRIAN A HEMSTREET PHARM D FCCP BCPS
TRUSTEE
- Total calculated
- $0
- Hours/week
- 1
-
SHELDON G HOLSTAD PHARM D
SECRETARY & DIRECTOR
- Total calculated
- $307,260
- From this org
- $138,208
- From related orgs
- $138,208
- Other
- $30,844
- Hours/week
- 20 + 20 related
Schedule J breakdown matched by us
- Base
- $138,208 + $138,208 related
- Bonus
- $0
- Other
- $0
- Deferred
- $6,481 + $6,481 related
- Nontaxable benefits
- $8,941 + $8,941 related
- Filer's total
- $153,630 + $153,630 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$27,930
GRANTS AND AWARDS
-
GRANTS AND AWARDS
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
AMERICAN COLLEGE OF CLINICAL PHARMACY
501C6 · EDUCATION · MO
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 29 April 2024
- IRS schema version
- 2023v5.0
- Source object
- 202401219349302070
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.